CFZ 300 (Invokana 300 mg)
Generic Name: canagliflozin
Pill with imprint CFZ 300 is White, Capsule-shape and has been identified as Invokana 300 mg. It is supplied by Janssen Pharmaceuticals, Inc.
Invokana is used in the treatment of diabetes, type 2; diabetic kidney disease; cardiovascular risk reduction and belongs to the drug class SGLT-2 inhibitors. Risk cannot be ruled out during pregnancy. Invokana 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CFZ 300
Invokana
- Generic Name
- canagliflozin
- Imprint
- CFZ 300
- Strength
- 300 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- SGLT-2 inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Janssen Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 50458-0141
- Inactive Ingredients
-
lactose anhydrous,
microcrystalline cellulose,
croscarmellose sodium,
magnesium stearate,
water,
titanium dioxide,
polyethylene glycol 3350,
magnesium silicate
Note: Inactive ingredients may vary.
More about Invokana (canagliflozin)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (257)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: SGLT-2 inhibitors
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.